Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV2 COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT07069309
What this trial is testing

Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

Who this might be right for
COVID-19SARS-COV-2 Infection
BioNTech SE 774
Testing effectiveness (Phase 2)Study completedNCT05109598
What this trial is testing

Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT05198063
What this trial is testing

ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization

Who this might be right for
Prevention of COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Early research (Phase 1)UnknownNCT06048393
What this trial is testing

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT06847204
What this trial is testing

EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL

Who this might be right for
COVID - 19
Zaeema Kanwal 66
Testing effectiveness (Phase 2)WithdrawnNCT04386447
What this trial is testing

Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19

Who this might be right for
Covid-19Corona Virus InfectionSARS-CoV 2
Azienda Ospedaliero-Universitaria di Parma
Not applicableStudy completedNCT05334758
What this trial is testing

Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test

Who this might be right for
COVID-19
BioTeke USA, LLC 282
Testing effectiveness (Phase 2)WithdrawnNCT05035238
What this trial is testing

Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

Who this might be right for
Covid19
Health Institutes of Turkey
Not applicableStudy completedNCT04483622
What this trial is testing

Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients

Who this might be right for
Covid19
Sohag University 33
Large-scale testing (Phase 3)Study completedNCT04505722
What this trial is testing

Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants

Who this might be right for
Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol
Janssen Vaccines & Prevention B.V. 44,325
Large-scale testing (Phase 3)UnknownNCT04425837
What this trial is testing

Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19

Who this might be right for
Sars-CoV2Covid-19
Fundación Santa Fe de Bogota 236
Not applicableWithdrawnNCT04812327
What this trial is testing

Capturing Infectious COVID-19 Asymptomatic Cases in Singapore

Who this might be right for
Covid19SARS CoV-2
Becton, Dickinson and Company
Not applicableStudy completedNCT04402827
What this trial is testing

Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.

Who this might be right for
Health Care Worker Patient TransmissionReceptor Site AlterationSusceptibility, Disease+1 more
Asociacion para el Estudio de las Enfermedades Infecciosas 140
Not applicableStudy completedNCT04363788
What this trial is testing

Needle Stick Injuries in Emergency Medical Service Practice

Who this might be right for
Cardiac ArrestNeedle StickInjuries+1 more
Lazarski University 300
Not applicableStudy completedNCT04750629
What this trial is testing

Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)

Who this might be right for
SARS-CoV-2Covid19
Lumos Diagnostics 140
Not applicableUnknownNCT04362345
What this trial is testing

Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia

Who this might be right for
Covid-19
University Hospital, Strasbourg, France 100
Not applicableStudy completedNCT04498286
What this trial is testing

COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Zoé van Kempen 546
Not applicableUnknownNCT05162456
What this trial is testing

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation

Who this might be right for
SARS-CoV2 InfectionSARS-CoV2 Antibodies
Collegium Medicum w Bydgoszczy 250
Not applicableEnded earlyNCT05655546
What this trial is testing

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Who this might be right for
ImmunodeficiencyImmunosuppressionHIV Infections+7 more
Scripps Translational Science Institute 2,117
Early research (Phase 1)UnknownNCT04428073
What this trial is testing

Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Who this might be right for
COVID
GeneCure Biotechnologies 32
Next Page